Full-Time

Director – Mass Spectrometry & Immunopeptidomics

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Expert

Cambridge, MA, USA

70/30 work model requiring 70% in-office presence.

Category
Bioinformatics
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in Immunology, Biochemistry, Molecular Biology, or a related field.
  • A minimum of 9 years of postdoctoral experience in immunopeptidomic analyses related to cancer vaccine discovery, validation and early development.
  • Extensive experience with LC-MS/MS and related proteomic technologies, including in depth knowledge of state-of-the-art equipment from Bruker and Thermo Fisher.
  • Proficiency in bioinformatics tools and software used in immunopeptidomic analysis.
  • Strong track record of team and project leadership, and scientific publications in the field of cancer vaccines and/or immunopeptidomics.
  • Excellent leadership, communication, collaboration and project management skills.
  • Ability to work in a fast-paced, dynamic, team-oriented environment working on multiple projects with aggressive timelines.
Responsibilities
  • Lead, manage and expand the MS and immunopeptidomic analysis workflows in the context of cancer vaccine research, including sample preparation, LC-MS/MS analysis, and data interpretation; for target discovery and validation, as well as related efforts to further characterize and optimize our cancer vaccine platform.
  • Build internal and leverage external resources to ensure utilization and leverage of cutting edge technologies and processes.
  • Develop and implement new methods and technologies to enhance immunopeptidomic analysis capabilities for the discovery and validation of tumor-associated antigens and neoantigens.
  • Collaborate with the Computational Sciences team to analyze and interpret immunopeptidomic data, and integrate it with genomic and transcriptomic data to guide the design of cancer vaccines.
  • Provide scientific leadership and guidance to team members, fostering an environment of innovation and excellence.
  • Collaborate with other research teams to integrate immunopeptidomic data with other research areas, such as immune monitoring and vaccine efficacy studies.
  • Contribute to the writing and reviewing of scientific manuscripts, grants, and patents related to cancer vaccine research.
  • Present findings at internal meetings and international conferences.
  • Ensure compliance with all applicable regulations and maintain up-to-date knowledge of literature in the field of cancer vaccines and immunopeptidomics.
  • Serve as further nucleus and leader in our across company MS Working team (including individuals in Protein Sciences, Infectious Disease Research, Technical Development and Immune Therapeutics Discovery).

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the speed and efficiency of drug discovery and manufacturing. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments for a range of health conditions.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

15%

2 year growth

48%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's AI-driven drug discovery accelerates novel mRNA-based therapeutics identification.
  • Expansion in Asia enhances global supply chain and reduces production costs.
  • mRNA technology is gaining traction for non-infectious disease vaccines, like cancer.

What critics are saying

  • Potential Nasdaq 100 removal could impact stock visibility and investor interest.
  • Bypassing safety steps in Australia may raise regulatory and public scrutiny concerns.
  • Hong Kong's reluctance to receive Covid-19 jab affects market penetration and sales.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for a new class of medicines.
  • The company focuses on mRNA's potential to transform drug discovery and manufacturing.
  • Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE